Fortress Biotech, Inc.
FBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429260
No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.
Other share classesFBIOP
Q4 2021 vs. Q3 2021
How the institutions holding Fortress Biotech, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 79 | 1 | 82 | +4 |
| Shares | 30.3M | 10.7K | 32.3M | +2.08M (+6.9%) |
| Value | $97.5M | $34.0K | $81.1M | −$16.3M (−16.7%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Fortress Biotech, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 439,227 | $1.10M | 0.01% |
| Acadian Asset Management LLC | 157,840 | $394.0K | 0.00% |
| Allspring Global Investments Holdings, LLC | 130,119 | $325.0K | 0.00% |
| Renaissance Technologies LLC | 99,647 | $249.0K | 0.00% |
| PVG Asset Management Corp | 99,145 | $247.9K | 0.91% |
| Jump Financial, LLC | 52,459 | $131.0K | 0.01% |
| Susquehanna Fundamental Investments, LLC | 39,985 | $100.0K | 0.00% |
| Simplex Trading, LLC | 39,036 | $97.0K | 0.00% |
| Parametric Portfolio Associates LLC | 35,177 | $88.0K | 0.00% |
| Lazard Asset Management LLC | 22,630 | $56.0K | 0.00% |
| ProShare Advisors LLC | 16,262 | $41.0K | 0.00% |
| Thompson Davis & Co., Inc. | 12,996 | $32.0K | 0.03% |
| Marshall Wace, LLP | 12,153 | $30.0K | 0.00% |
| First Manhattan Co | 2,549 | $6.00K | 0.00% |
| Covestor Ltd | 177 | $0 | 0.00% |
Sold out (11)
Institutions that held Fortress Biotech, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Gsa Capital Partners LLP | 187,178 | $603.0K |
| Two Sigma Investments, LP | 89,018 | $287.0K |
| Telemetry Investments, L.L.C. | 55,000 | $177.0K |
| Summit Global Investments | 44,900 | $145.0K |
| Virtu Financial LLC | 25,714 | $83.0K |
| SG Americas Securities, LLC | 24,618 | $79.0K |
| Gladstone Institutional Advisory LLC | 10,940 | $35.0K |
| Two Sigma Securities, LLC | 10,120 | $33.0K |
| O'Shaughnessy Asset Management, LLC | 1,905 | $6.00K |
| Phoenix Wealth Advisors | 800 | $3.00K |
| Ellevest, Inc. | 50 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Fortress Biotech, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Spotlight Asset Group, Inc. | 10,700 | $34.0K |